0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Virus Rapid Antigen Test Kit Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-10D16892
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Virus Rapid Antigen Test Kit Market Research Report 2024
BUY CHAPTERS

Global Influenza Virus Rapid Antigen Test Kit Market Research Report 2026

Code: QYRE-Auto-10D16892
Report
2026-04-16
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Influenza Virus Rapid Antigen Test Kit Market Size

The global Influenza Virus Rapid Antigen Test Kit market was valued at US$ 232 million in 2025 and is anticipated to reach US$ 310 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Influenza Virus Rapid Antigen Test Kit Market

Influenza Virus Rapid Antigen Test Kit Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Influenza Virus Rapid Antigen Test Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.
The North American market for Influenza Virus Rapid Antigen Test Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Influenza Virus Rapid Antigen Test Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Influenza Virus Rapid Antigen Test Kit include BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Influenza Virus Rapid Antigen Test Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Influenza Virus Rapid Antigen Test Kit. The Influenza Virus Rapid Antigen Test Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Influenza Virus Rapid Antigen Test Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Influenza Virus Rapid Antigen Test Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Influenza Virus Rapid Antigen Test Kit Market Report

Report Metric Details
Report Name Influenza Virus Rapid Antigen Test Kit Market
Accounted market size in 2025 US$ 232 million
Forecasted market size in 2032 US$ 310 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Conventional RIDT
  • Digital RIDT
by Application
  • Hospital
  • POCT
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Influenza Virus Rapid Antigen Test Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Influenza Virus Rapid Antigen Test Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Influenza Virus Rapid Antigen Test Kit Market growing?

Ans: The Influenza Virus Rapid Antigen Test Kit Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Influenza Virus Rapid Antigen Test Kit Market size in 2032?

Ans: The Influenza Virus Rapid Antigen Test Kit Market size in 2032 will be US$ 310 million.

Who are the main players in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The main players in the Influenza Virus Rapid Antigen Test Kit Market are BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene

What are the Application segmentation covered in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The Applications covered in the Influenza Virus Rapid Antigen Test Kit Market report are Hospital, POCT, Others

What are the Type segmentation covered in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The Types covered in the Influenza Virus Rapid Antigen Test Kit Market report are Conventional RIDT, Digital RIDT

1 Influenza Virus Rapid Antigen Test Kit Market Overview
1.1 Product Definition
1.2 Influenza Virus Rapid Antigen Test Kit by Type
1.2.1 Global Influenza Virus Rapid Antigen Test Kit Market Value by Type: 2025 vs 2032
1.2.2 Conventional RIDT
1.2.3 Digital RIDT
1.3 Influenza Virus Rapid Antigen Test Kit by Application
1.3.1 Global Influenza Virus Rapid Antigen Test Kit Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 POCT
1.3.4 Others
1.4 Global Influenza Virus Rapid Antigen Test Kit Market Size Estimates and Forecasts
1.4.1 Global Influenza Virus Rapid Antigen Test Kit Revenue 2021–2032
1.4.2 Global Influenza Virus Rapid Antigen Test Kit Sales 2021–2032
1.4.3 Global Influenza Virus Rapid Antigen Test Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Influenza Virus Rapid Antigen Test Kit Market Competition by Manufacturers
2.1 Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Influenza Virus Rapid Antigen Test Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Product Types and Applications
2.7 Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Date of Entry into the Industry
2.8 Global Influenza Virus Rapid Antigen Test Kit Market Competitive Situation and Trends
2.8.1 Global Influenza Virus Rapid Antigen Test Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Influenza Virus Rapid Antigen Test Kit Players Market Share by Revenue
2.8.3 Global Influenza Virus Rapid Antigen Test Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza Virus Rapid Antigen Test Kit Market Scenario by Region
3.1 Global Influenza Virus Rapid Antigen Test Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Influenza Virus Rapid Antigen Test Kit Sales by Region: 2021–2032
3.2.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Region: 2021–2026
3.2.2 Global Influenza Virus Rapid Antigen Test Kit Sales by Region: 2027–2032
3.3 Global Influenza Virus Rapid Antigen Test Kit Revenue by Region: 2021–2032
3.3.1 Global Influenza Virus Rapid Antigen Test Kit Revenue by Region: 2021–2026
3.3.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Region: 2027–2032
3.4 North America Influenza Virus Rapid Antigen Test Kit Market Facts & Figures by Country
3.4.1 North America Influenza Virus Rapid Antigen Test Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Influenza Virus Rapid Antigen Test Kit Sales by Country (2021–2032)
3.4.3 North America Influenza Virus Rapid Antigen Test Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza Virus Rapid Antigen Test Kit Market Facts & Figures by Country
3.5.1 Europe Influenza Virus Rapid Antigen Test Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Influenza Virus Rapid Antigen Test Kit Sales by Country (2021–2032)
3.5.3 Europe Influenza Virus Rapid Antigen Test Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Virus Rapid Antigen Test Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza Virus Rapid Antigen Test Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Influenza Virus Rapid Antigen Test Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific Influenza Virus Rapid Antigen Test Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza Virus Rapid Antigen Test Kit Market Facts & Figures by Country
3.7.1 Latin America Influenza Virus Rapid Antigen Test Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Influenza Virus Rapid Antigen Test Kit Sales by Country (2021–2032)
3.7.3 Latin America Influenza Virus Rapid Antigen Test Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Type (2021–2032)
4.1.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Type (2021–2026)
4.1.2 Global Influenza Virus Rapid Antigen Test Kit Sales by Type (2027–2032)
4.1.3 Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Type (2021–2032)
4.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Type (2021–2032)
4.2.1 Global Influenza Virus Rapid Antigen Test Kit Revenue by Type (2021–2026)
4.2.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Type (2027–2032)
4.2.3 Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type (2021–2032)
4.3 Global Influenza Virus Rapid Antigen Test Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Application (2021–2032)
5.1.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Application (2021–2026)
5.1.2 Global Influenza Virus Rapid Antigen Test Kit Sales by Application (2027–2032)
5.1.3 Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Application (2021–2032)
5.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Application (2021–2032)
5.2.1 Global Influenza Virus Rapid Antigen Test Kit Revenue by Application (2021–2026)
5.2.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Application (2027–2032)
5.2.3 Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2021–2032)
5.3 Global Influenza Virus Rapid Antigen Test Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BD Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Quidel
6.3.1 Quidel Company Information
6.3.2 Quidel Description and Business Overview
6.3.3 Quidel Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Quidel Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.3.5 Quidel Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Roche Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Actim
6.5.1 Actim Company Information
6.5.2 Actim Description and Business Overview
6.5.3 Actim Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Actim Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.5.5 Actim Recent Developments/Updates
6.6 Denka
6.6.1 Denka Company Information
6.6.2 Denka Description and Business Overview
6.6.3 Denka Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Denka Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.6.5 Denka Recent Developments/Updates
6.7 Guangzhou Wondfo Biotech
6.7.1 Guangzhou Wondfo Biotech Company Information
6.7.2 Guangzhou Wondfo Biotech Description and Business Overview
6.7.3 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
6.8 Jiangsu Bioperfectus Technologies
6.8.1 Jiangsu Bioperfectus Technologies Company Information
6.8.2 Jiangsu Bioperfectus Technologies Description and Business Overview
6.8.3 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.8.5 Jiangsu Bioperfectus Technologies Recent Developments/Updates
6.9 Hangzhou Biotest Biotech
6.9.1 Hangzhou Biotest Biotech Company Information
6.9.2 Hangzhou Biotest Biotech Description and Business Overview
6.9.3 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.9.5 Hangzhou Biotest Biotech Recent Developments/Updates
6.10 Wantai BioPharm
6.10.1 Wantai BioPharm Company Information
6.10.2 Wantai BioPharm Description and Business Overview
6.10.3 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.10.5 Wantai BioPharm Recent Developments/Updates
6.11 Daan Gene
6.11.1 Daan Gene Company Information
6.11.2 Daan Gene Description and Business Overview
6.11.3 Daan Gene Influenza Virus Rapid Antigen Test Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Daan Gene Influenza Virus Rapid Antigen Test Kit Product Portfolio
6.11.5 Daan Gene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Virus Rapid Antigen Test Kit Industry Chain Analysis
7.2 Influenza Virus Rapid Antigen Test Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Virus Rapid Antigen Test Kit Production Mode & Process Analysis
7.4 Influenza Virus Rapid Antigen Test Kit Sales and Marketing
7.4.1 Influenza Virus Rapid Antigen Test Kit Sales Channels
7.4.2 Influenza Virus Rapid Antigen Test Kit Distributors
7.5 Influenza Virus Rapid Antigen Test Kit Customer Analysis
8 Influenza Virus Rapid Antigen Test Kit Market Dynamics
8.1 Influenza Virus Rapid Antigen Test Kit Industry Trends
8.2 Influenza Virus Rapid Antigen Test Kit Market Drivers
8.3 Influenza Virus Rapid Antigen Test Kit Market Challenges
8.4 Influenza Virus Rapid Antigen Test Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Influenza Virus Rapid Antigen Test Kit Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Influenza Virus Rapid Antigen Test Kit Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Influenza Virus Rapid Antigen Test Kit Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Influenza Virus Rapid Antigen Test Kit Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Influenza Virus Rapid Antigen Test Kit Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Influenza Virus Rapid Antigen Test Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Influenza Virus Rapid Antigen Test Kit, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Product Types and Applications
 Table 12. Global Key Manufacturers of Influenza Virus Rapid Antigen Test Kit, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Influenza Virus Rapid Antigen Test Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on Influenza Virus Rapid Antigen Test Kit Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Influenza Virus Rapid Antigen Test Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Influenza Virus Rapid Antigen Test Kit Sales by Region (K Units), 2021–2026
 Table 18. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Region (2021–2026)
 Table 19. Global Influenza Virus Rapid Antigen Test Kit Sales by Region (K Units), 2027–2032
 Table 20. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Region (2027–2032)
 Table 21. Global Influenza Virus Rapid Antigen Test Kit Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Region (2021–2026)
 Table 23. Global Influenza Virus Rapid Antigen Test Kit Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Region (2027–2032)
 Table 25. North America Influenza Virus Rapid Antigen Test Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2021–2026
 Table 27. North America Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2027–2032
 Table 28. North America Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Influenza Virus Rapid Antigen Test Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2021–2026
 Table 32. Europe Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2027–2032
 Table 33. Europe Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Influenza Virus Rapid Antigen Test Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Influenza Virus Rapid Antigen Test Kit Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Influenza Virus Rapid Antigen Test Kit Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Influenza Virus Rapid Antigen Test Kit Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Influenza Virus Rapid Antigen Test Kit Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Influenza Virus Rapid Antigen Test Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2021–2026
 Table 42. Latin America Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2027–2032
 Table 43. Latin America Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Type (2021–2026)
 Table 51. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Type (2027–2032)
 Table 52. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Type (2021–2026)
 Table 53. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Type (2027–2032)
 Table 54. Global Influenza Virus Rapid Antigen Test Kit Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Influenza Virus Rapid Antigen Test Kit Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type (2021–2026)
 Table 57. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type (2027–2032)
 Table 58. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Application (2021–2026)
 Table 61. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Application (2027–2032)
 Table 62. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Application (2021–2026)
 Table 63. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Application (2027–2032)
 Table 64. Global Influenza Virus Rapid Antigen Test Kit Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Influenza Virus Rapid Antigen Test Kit Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2021–2026)
 Table 67. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2027–2032)
 Table 68. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Application (2027–2032)
 Table 70. BD Company Information
 Table 71. BD Description and Business Overview
 Table 72. BD Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. BD Influenza Virus Rapid Antigen Test Kit Product
 Table 74. BD Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Abbott Influenza Virus Rapid Antigen Test Kit Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Quidel Company Information
 Table 81. Quidel Description and Business Overview
 Table 82. Quidel Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Quidel Influenza Virus Rapid Antigen Test Kit Product
 Table 84. Quidel Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Roche Influenza Virus Rapid Antigen Test Kit Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Actim Company Information
 Table 91. Actim Description and Business Overview
 Table 92. Actim Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Actim Influenza Virus Rapid Antigen Test Kit Product
 Table 94. Actim Recent Developments/Updates
 Table 95. Denka Company Information
 Table 96. Denka Description and Business Overview
 Table 97. Denka Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Denka Influenza Virus Rapid Antigen Test Kit Product
 Table 99. Denka Recent Developments/Updates
 Table 100. Guangzhou Wondfo Biotech Company Information
 Table 101. Guangzhou Wondfo Biotech Description and Business Overview
 Table 102. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product
 Table 104. Guangzhou Wondfo Biotech Recent Developments/Updates
 Table 105. Jiangsu Bioperfectus Technologies Company Information
 Table 106. Jiangsu Bioperfectus Technologies Description and Business Overview
 Table 107. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product
 Table 109. Jiangsu Bioperfectus Technologies Recent Developments/Updates
 Table 110. Hangzhou Biotest Biotech Company Information
 Table 111. Hangzhou Biotest Biotech Description and Business Overview
 Table 112. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product
 Table 114. Hangzhou Biotest Biotech Recent Developments/Updates
 Table 115. Wantai BioPharm Company Information
 Table 116. Wantai BioPharm Description and Business Overview
 Table 117. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product
 Table 119. Wantai BioPharm Recent Developments/Updates
 Table 120. Daan Gene Company Information
 Table 121. Daan Gene Description and Business Overview
 Table 122. Daan Gene Influenza Virus Rapid Antigen Test Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Daan Gene Influenza Virus Rapid Antigen Test Kit Product
 Table 124. Daan Gene Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Influenza Virus Rapid Antigen Test Kit Distributors List
 Table 128. Influenza Virus Rapid Antigen Test Kit Customers List
 Table 129. Influenza Virus Rapid Antigen Test Kit Market Trends
 Table 130. Influenza Virus Rapid Antigen Test Kit Market Drivers
 Table 131. Influenza Virus Rapid Antigen Test Kit Market Challenges
 Table 132. Influenza Virus Rapid Antigen Test Kit Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Influenza Virus Rapid Antigen Test Kit
 Figure 2. Global Influenza Virus Rapid Antigen Test Kit Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Influenza Virus Rapid Antigen Test Kit Market Share by Type: 2025 & 2032
 Figure 4. Conventional RIDT Product Picture
 Figure 5. Digital RIDT Product Picture
 Figure 6. Global Influenza Virus Rapid Antigen Test Kit Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Influenza Virus Rapid Antigen Test Kit Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. POCT
 Figure 10. Others
 Figure 11. Global Influenza Virus Rapid Antigen Test Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Influenza Virus Rapid Antigen Test Kit Market Size (US$ Million), 2021–2032
 Figure 13. Global Influenza Virus Rapid Antigen Test Kit Sales (K Units), 2021–2032
 Figure 14. Global Influenza Virus Rapid Antigen Test Kit Average Price (US$/Unit), 2021–2032
 Figure 15. Influenza Virus Rapid Antigen Test Kit Report Years Considered
 Figure 16. Influenza Virus Rapid Antigen Test Kit Sales Share by Manufacturers in 2025
 Figure 17. Global Influenza Virus Rapid Antigen Test Kit Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Influenza Virus Rapid Antigen Test Kit Players: Market Share by Revenue in Influenza Virus Rapid Antigen Test Kit in 2025
 Figure 19. Influenza Virus Rapid Antigen Test Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Influenza Virus Rapid Antigen Test Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Influenza Virus Rapid Antigen Test Kit Sales Market Share by Country (2021–2032)
 Figure 22. North America Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Country (2021–2032)
 Figure 23. United States Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Influenza Virus Rapid Antigen Test Kit Sales Market Share by Country (2021–2032)
 Figure 26. Europe Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Influenza Virus Rapid Antigen Test Kit Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Region (2021–2032)
 Figure 34. China Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Influenza Virus Rapid Antigen Test Kit Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Influenza Virus Rapid Antigen Test Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Influenza Virus Rapid Antigen Test Kit by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Influenza Virus Rapid Antigen Test Kit by Type (2021–2032)
 Figure 54. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Influenza Virus Rapid Antigen Test Kit by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Influenza Virus Rapid Antigen Test Kit by Application (2021–2032)
 Figure 57. Global Influenza Virus Rapid Antigen Test Kit Price (US$/Unit) by Application (2021–2032)
 Figure 58. Influenza Virus Rapid Antigen Test Kit Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners